Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × remibrutinib × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

pembrolizumab 263 Carboplatin 194 Paclitaxel 138 Cisplatin 135 Gemcitabine 119 Pemetrexed 105 Bevacizumab 101 Docetaxel 86 atezolizumab 72 Oxaliplatin 70 durvalumab 67 Nivolumab 67 Cyclophosphamide 65 Fluorouracil 64 Capecitabine 64 Injections 63 Dexamethasone 62 Fulvestrant 60 130-nm albumin-bound paclitaxel 56 Leucovorin 52 Rituximab 51 Cetuximab 51 Prednisone 47 Lenalidomide 46 Trastuzumab 42 venetoclax 41 fludarabine 40 enzalutamide 39 Irinotecan 37 Letrozole 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06744920 2026-02-20

RELIEVE

Novartis

Phase 3 Recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡